Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas

The prediction of clinical outcome for patients with infiltrative gliomas is challenging. Although preoperative hematological markers have been proposed as predictors of survival in glioma and other cancers, systematic investigations that combine these data with other relevant clinical variables are...

Full description

Saved in:
Bibliographic Details
Published in:Aging (Albany, NY.) NY.), 2019-08, Vol.11 (16), p.6252-6272
Main Authors: Zhang, Zhen-Yu, Zhan, Yun-Bo, Zhang, Feng-Jiang, Yu, Bin, Ji, Yu-Chen, Zhou, Jin-Qiao, Bai, Ya-Hui, Wang, Yan-Min, Wang, Li, Jing, Yan, Duan, Wen-Chao, Sun, Chen, Sun, Tao, Zhao, Hai-Biao, Li, Ke, Wang, Wen-Qing, Li, Ruo-Yan, Sun, Hong-Wei, Zhai, Guang, Wang, Shu-Kai, Wei, Xin-Ting, Yang, Bo, Yan, Dong-Ming, Liu, Xian-Zhi, Wang, Wei-Wei
Format: Article
Language:English
Subjects:
Research Paper
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The prediction of clinical outcome for patients with infiltrative gliomas is challenging. Although preoperative hematological markers have been proposed as predictors of survival in glioma and other cancers, systematic investigations that combine these data with other relevant clinical variables are needed to improve prognostic accuracy and patient outcomes. We investigated the prognostic value of preoperative hematological markers, alone and in combination with molecular pathology, for the survival of 592 patients with Grade II-IV diffuse gliomas. On univariate analysis, increased neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), and decreased albumin-to-globulin ratio (AGR), all predicted poor prognosis in Grade II/III gliomas. Multivariate analysis incorporating tumor status based on the presence of mutations, promoter mutations, and 1p/19q codeletion showed that in lower-grade gliomas, high NLR predicted poorer survival for the triple-negative, IDH mutation only, TERT mutation only, and IDH and TERT mutation groups. NLR was an independent prognostic factor in Grade IV glioma. We therefore propose a prognostic model for diffuse gliomas based on the presence of and promoter mutations, 1p/19q codeletion, and NLR. This model classifies lower-grade gliomas into nine subgroups that can be combined into four main risk groups based on survival projections.
ISSN:1945-4589
1945-4589
DOI:10.18632/aging.102186